{
    "N/R/U": null,
    "Applicant": "Grifols Therapeutics LLC",
    "BLA Number": "101134",
    "Proprietary Name": "Baygam, Gamastan S/D",
    "Proper Name": "Immune Globulin (Human)",
    "BLA Type": "351(a)",
    "Strength": "16.50%",
    "Dosage Form": "Injection",
    "Route of Administration": "Intramuscular",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "11-Jan-44",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "1871",
    "Product Number": "1",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}